We have been selected for the “Research and Development Program for Innovative Biologics” in 2024. 2024/09/12 Notice Read
Notice of a collaboration agreement with Renascience, Inc. to develop antisense oligonucleotides for treating hereditary neurological intractable diseases 2024/06/24 Notice Read
We will give a presentation at the 9th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan. 2024/05/31 Event Read
We will give a presentation at “The International Cell & Gene Therapy China Summit(CGCS)” in Nanjing, China. 2024/05/14 Event Read
We will participate in the BIO International Convention in San Diego, Massachusetts, United States. 2024/05/14 Event Read
Our President & CEO, Mr. Hideaki Sato, will participate in the “TIDES US 2024” as a speaker. 2024/05/13 Event Read
Our President & CEO, Mr. Hideaki Sato, will participate in “PharmaLab Expo OSAKA 2024” as a speaker. 2024/03/01 Event Read
